June 29, 2015
Cord Blood Registry
houses more than 600,000 preserved umbilical-cord blood and tissue stem
cell units, or more than half of all privately stored cord units in the
U.S., AMAG said in the release, citing estimates from the company....
When companies are bought and sold there can be a change in contracts with their customers. Parents need to look into this. I don't know if there are regulations regarding Cord Blood and it's registries.
GTCR reached an agreement to sell (click here) newborn stem cell business CBR Systems Inc. to publicly traded AMAG Pharmaceuticals Inc. for $700 million.
Waltham,
Mass.-based AMAG said in a news release that the acquisition would add
additional products and services in the consumer-health and
maternal-health markets.
Founded in 1992 and based in San Bruno, Calif., CBR Systems does business as Cord Blood Registry. The company preserves umbilical-cord blood stem cells and cord tissue samples for potential future medical use.
When companies are bought and sold there can be a change in contracts with their customers. Parents need to look into this. I don't know if there are regulations regarding Cord Blood and it's registries.
...Last
year, the company generated a pro forma revenue of about $126 million
and an adjusted earnings before interest, taxes, depreciation and
amortization of $45 million, AMAG said.
GTCR took a majority stake in Cord Blood Registry in September 2012 for an undisclosed amount. The investment was made from GTCR Fund X LP, a $3.25 billion fund raised in 2011, according to a news release at the time ....
This is a service to customers. I think. That is a really good income from registering Cord Blood.
...Data provider IBISWorld says U.S. blood and organ banks are a $11.9 billion business that is poised to grow at 2.9% in the five years ending 2019. It said the continuing health-care reform enables more individuals to afford such services, and technological innovations that enable researchers to create transplants from stem cells will likely stimulate demand for biobanking and related services....
According to this reporting, the sales and investment activity in these companies/products has been vigorous. I think the federal government needs to take a close look at this. A committee might be interesting.
...Data provider IBISWorld says U.S. blood and organ banks are a $11.9 billion business that is poised to grow at 2.9% in the five years ending 2019. It said the continuing health-care reform enables more individuals to afford such services, and technological innovations that enable researchers to create transplants from stem cells will likely stimulate demand for biobanking and related services....
According to this reporting, the sales and investment activity in these companies/products has been vigorous. I think the federal government needs to take a close look at this. A committee might be interesting.
